Concord Biotech Limited — Others, 24-12-2024: Trading Window

Concord Biotech Limited has announced a board meeting to discuss the financial results for the quarter and nine months ending December 31, 2024. The trading window for equity shares will be closed from January 1, 2025, until 48 hours after the results are made public, impacting all designated individuals and their immediate relatives from trading during this period. This closure is a standard compliance measure that may create a temporary sentiment shift among investors but reinforces corporate governance. Overall, investors should monitor this situation closely for potential fluctuations in share activity.